Smallpox Antiviral
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- BARDA-2021-Smallpox_Antiviral-01B
- Agency
- Office of the Assistant Secretary for Preparedness and Response Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
About this opportunity
BARDA seeks information from other than small businesses regarding the development and manufacture of FDA-approved smallpox antiviral drugs with alternative mechanisms of action to TPOXX. Respondents must have an NDA or BLA submitted to and acknowledged by the FDA, with a confirmed PDUFA date, and must demonstrate the ability to manufacture and deliver final drug product and fulfill all post-marketing requirements. Responses to the Sources Sought Notice must not exceed 10 pages each for business and technical representations and are due by April 8, 2021.
No set-aside designation was used. BARDA will use responses for potential future acquisitions related to procuring, stockpiling, and developing additional smallpox antivirals. Current incumbent is not listed. Responses should include details on company and regulatory status, clinical development, manufacturing capacity, and product shelf life to aid BARDA's market research.
Notice text
BARDA seeks pertinent marketplace data on availabilities and capabilities for procuring, stockpiling, and investing in the development of FDA-approved smallpox antiviral(s) with alternative mechanism(s) of action to TPOXX®.
Please see attached Sources Sought Notice for additional details.
Attachments
| File | Type | Posted |
|---|---|---|
| Smallpox_2021_OTSBSSN.doc | DOC document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Smallpox Antiviral | Limited / Sole Source Justification | |
| Smallpox Antiviral | Award Notice | |
| Smallpox Antiviral | Solicitation | |
| Smallpox Antiviral | Pre-Solicitation | |
| Smallpox Antiviral | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity